# Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

> **NCT06987708** · NA · NOT_YET_RECRUITING · sponsor: **Hackensack Meridian Health** · enrollment: 67 (estimated)

## Conditions studied

- Monoclonal Gammopathy of Uncertain Significance
- Smoldering Myeloma

## Interventions

- **OTHER:** The Multimodal Lifestyle Intervention

## Key facts

- **NCT ID:** NCT06987708
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 67 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987708, "Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06987708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*